Switching from neutral protamine Hagedorn (NPH) insulin to insulin glargine 300 U/mL in older and younger patients with type 2 diabetes - a post hoc analysis of a multicenter, prospective, observational study

Version 2 2022-08-02, 12:09

Version 1 2022-05-25, 16:22

media

posted on 2022-08-02, 12:09 authored by B. Wolnik, T. Klupa, T. Szczepanik, D. Pisarczyk-Wiza, A. Hryniewiecki

Article full text

The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.

There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).